ID BIONi010-C AC CVCL_1E68 SY K3_shp53; K3P53 DR BioSamples; SAMEA3158050 DR EBiSC; BIONi010-C DR ECACC; 66540023 DR EGA; EGAS00001002755 DR GEO; GSM1183107 DR hPSCreg; BIONi010-C DR SKIP; SKIP002536 DR Wikidata; Q54796750 RX PubMed=25241739; RX PubMed=27596958; RX PubMed=30660866; RX PubMed=33660062; CC From: Bioneer A/S; Horsholm; Denmark. CC Population: African. CC Omics: Genomics; Whole genome sequencing. CC Omics: Transcriptomics; Microarray. CC Discontinued: ECACC; 66540023; true. CC Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067. CC Cell type: Fibroblast of skin; CL=CL_0002620. ST Source(s): Bioneer ST Amelogenin: X,Y ST CSF1PO: 10,12 ST D13S317: 11,12 ST D16S539: 10,12 ST D18S51: 13,16 ST D19S433: 13,14.2 ST D21S11: 28,32.2 ST D2S1338: 22,23 ST D3S1358: 15,16 ST D5S818: 11,13 ST D7S820: 9,11 ST D8S1179: 13,14 ST FGA: 21,24 ST TH01: 7,9.3 ST TPOX: 8,11 ST vWA: 17 OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_1E66 ! BIONi010-A OI CVCL_1E67 ! BIONi010-B SX Male AG 18Y CA Induced pluripotent stem cell DT Created: 08-07-15; Last updated: 10-04-25; Version: 18 CH CVCL_RM84 ! BIONi010-C-10 CH CVCL_RM85 ! BIONi010-C-11 CH CVCL_RM86 ! BIONi010-C-12 CH CVCL_RF90 ! BIONi010-C-13 CH CVCL_RM87 ! BIONi010-C-15 CH CVCL_RM88 ! BIONi010-C-17 CH CVCL_RM89 ! BIONi010-C-18 CH CVCL_VC57 ! BIONi010-C-19 CH CVCL_II81 ! BIONi010-C-2 CH CVCL_VC58 ! BIONi010-C-24 CH CVCL_VC59 ! BIONi010-C-25 CH CVCL_VR96 ! BIONi010-C-29 CH CVCL_II82 ! BIONi010-C-3 CH CVCL_VR97 ! BIONi010-C-30 CH CVCL_UR26 ! BIONi010-C-37 CH CVCL_UR27 ! BIONi010-C-38 CH CVCL_II83 ! BIONi010-C-4 CH CVCL_II84 ! BIONi010-C-5 CH CVCL_C9MD ! BIONi010-C-51 CH CVCL_C9MC ! BIONi010-C-52 CH CVCL_C9MB ! BIONi010-C-53 CH CVCL_C9MA ! BIONi010-C-54 CH CVCL_C9H1 ! BIONi010-C-56 CH CVCL_C9H2 ! BIONi010-C-57 CH CVCL_C9H3 ! BIONi010-C-58 CH CVCL_C9H4 ! BIONi010-C-59 CH CVCL_II85 ! BIONi010-C-6 CH CVCL_C9H5 ! BIONi010-C-60 CH CVCL_C9H6 ! BIONi010-C-61 CH CVCL_C9H7 ! BIONi010-C-62 CH CVCL_C9H8 ! BIONi010-C-63 CH CVCL_C1NT ! BIONi010-C-64 CH CVCL_II86 ! BIONi010-C-7 CH CVCL_D6RS ! BIONi010-C-70 CH CVCL_D6RT ! BIONi010-C-71 CH CVCL_D6RU ! BIONi010-C-72 CH CVCL_LE09 ! BIONi010-C-8 CH CVCL_LL40 ! BIONi010-C-9 CH CVCL_C0VT ! BIONi010-C-NKX2.5-T2A-Nluc-44.37 CH CVCL_C0VU ! BIONi010-C-NKX2.5-T2A-Nluc-73.59 CH CVCL_D6PB ! BIONi010C-48 // RX PubMed=25241739; DOI=10.1016/j.stemcr.2014.07.006; PMCID=PMC4266010; RA Rasmussen, Mikkel Aabech RA Holst, Bjorn RA Tumer, Zeynep RA Johnsen, Mads G. RA Zhou, Shu-Ling RA Stummann, Tina C. RA Hyttel, Poul RA Clausen, Christian RT "Transient p53 suppression increases reprogramming of human RT fibroblasts without affecting apoptosis and DNA damage."; RL Stem Cell Reports 3:404-413(2014). // RX PubMed=33660062; DOI=10.1007/s00204-021-03018-y; PMCID=PMC8113199; RA Lauschke, Karin RA Treschow, Andreas Frederik RA Rasmussen, Mikkel Aabech RA Davidsen, Nichlas RA Holst, Bjorn RA Emneus, Jenny RA Taxvig, Camilla RA Vinggaard, Anne Marie RT "Creating a human-induced pluripotent stem cell-based NKX2.5 reporter RT gene assay for developmental toxicity testing."; RL Arch. Toxicol. 95:1659-1670(2021). // RX PubMed=30660866; DOI=10.1016/j.scr.2018.11.010; RA Schmid, Benjamin RA Prehn, Kennie Rosairus RA Nimsanor, Natakarn RA Aldana Garcia, Blanca Irene RA Poulsen, Ulla Bekker RA Jorring, Ida RA Rasmussen, Mikkel Aabech RA Clausen, Christian RA Mau-Holzmann, Ulrike A. RA Ramakrishna, Sarayu RA Muddashetty, Ravi S. RA Steeg, Rachel RA Bruce, Kevin RA Mackintosh, Peter RA Ebneth, Andreas RA Holst, Bjorn RA Cabrera-Socorro, Alfredo RT "Generation of a set of isogenic, gene-edited iPSC lines homozygous RT for all main APOE variants and an APOE knock-out line."; RL Stem Cell Res. 34:101349-101349(2019). // RX PubMed=27596958; DOI=10.1016/j.scr.2016.07.004; RA Hansen, Susanne K. RA Stummann, Tina C. RA Borland, Helena RA Hasholt, Lis Frydenreich RA Tumer, Zeynep RA Nielsen, Jorgen E. RA Rasmussen, Mikkel Aabech RA Nielsen, Troels T. RA Daechsel, Justus C.A. RA Fog, Karina RA Hyttel, Poul RT "Induced pluripotent stem cell-derived neurons for the study of RT spinocerebellar ataxia type 3."; RL Stem Cell Res. 17:306-317(2016). //